文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

儿童左心室心肌致密化不全心肌病的长期结局:基于全国人群的研究

Long-Term Outcomes of Childhood Left Ventricular Noncompaction Cardiomyopathy: Results From a National Population-Based Study.
PubMed 文献 · Circulation · 2018-01-01

该研究基于澳大利亚全国儿童心肌病研究,纳入29例10岁前诊断的左心室心肌致密化不全(LVNC)患儿,平均年发病率0.11/10万高危个体。83%以充血性心力衰竭起病,93%为扩张型表型,中位诊断年龄0.3岁。诊断后10年无死亡或移植生存率48%,15年45%;倾向评分分析提示LVNC扩张型表型死亡或移植风险高于扩张型心肌病(HR 2.3,95%CI 1.4-3.8,P=0.0012)。

要点

  • 儿童LVNC多在小婴儿期以心衰起病,常表现为扩张型表型。
  • 诊断后15年无死亡或移植生存率仅45%,长期预后不佳。
  • LVNC扩张型表型死亡或移植风险显著高于扩张型心肌病。

核心结论

  • 有症状的儿童LVNC通常在小婴儿期起病,以扩张型表型为主,长期结局比匹配的扩张型心肌病患儿更差。

研究设计与样本

  • 全国人群-based队列研究(澳大利亚儿童心肌病研究),纳入1987至1996年间10岁前诊断的原发性心肌病患儿,其中LVNC 29例(占所有心肌病9.2%),采用倾向评分分析校正风险因素。

主要发现

  • LVNC平均年新诊断发病率为0.11/10万高危个体。
  • 29例中24例(83%)以充血性心力衰竭为首发症状,27例(93%)为扩张型表型。
  • 诊断中位年龄0.3岁(四分位间期0.08-1.3年)。
  • 诊断后10年无死亡或移植生存率48%(95%CI 30-65),15年45%(95%CI 27-63)。
  • 竞争风险分析显示15年时21%存活且左室收缩功能正常,31%存活但功能异常。

关键数值与推荐

  • 倾向评分匹配显示LVNC扩张型表型15年无死亡/移植生存率46%(95%CI 26-66),扩张型心肌病为70%(95%CI 42-97),P=0.08。
  • 倾向评分逆概率加权Cox回归显示LVNC扩张型表型与死亡或移植风险增加相关(HR 2.3,95%CI 1.4-3.8,P=0.0012)。

临床怎么用

  • 对婴儿期出现心衰且超声提示LVNC的患儿,应早期识别并加强监测,因其长期死亡或移植风险较高。

局限性

  • 样本量较小(29例),部分比较的置信区间较宽。
  • 研究纳入1987至1996年诊断的患儿,诊疗背景可能与当前不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term outcomes for childhood left ventricular noncompaction (LVNC) are uncertain. We examined late outcomes for children with LVNC enrolled in a national population-based study. METHODS: The National Australian Childhood Cardiomyopathy Study includes all children in Australia with primary cardiomyopathy diagnosed before 10 years of age between 1987 and 1996. Outcomes for subjects with LVNC with a dilated phenotype (LVNC-D) were compared with outcomes for those with dilated cardiomyopathy. Propensity-score analysis was used for risk factor adjustment. RESULTS: There were 29 subjects with LVNC (9.2% of all cardiomyopathy subjects), with a mean annual incidence of newly diagnosed cases of 0.11 per 100 000 at-risk individuals. Congestive heart failure was the initial symptom in 24 of 29 subjects (83%), and 27 (93%) had LVNC-D. The median age at diagnosis was 0.3 (interquartile interval, 0.08-1.3) years. The median duration of follow-up was 6.8 (interquartile interval, 0.7-24.0) years for all subjects and 24.7 (interquartile interval, 23.3 - 27.7) years for surviving subjects. Freedom from death or transplantation was 48% (95% confidence interval [CI], 30-65) at 10 years after diagnosis and 45% (95% CI, 27-63) at 15 years. In competing-risk analysis, 21% of subjects with LVNC were alive with normal left ventricular systolic function, and 31% were alive with abnormal function at 15 years. Propensity-score matching between subjects with LVNC-D and those with dilated cardiomyopathy suggested a lower freedom from death/transplantation at 15 years after diagnosis in the subjects with LVNC-D (LVNC-D, 46% [95% CI, 26-66] versus dilated cardiomyopathy, 70% [95% CI, 42-97]; P=0.08). Using propensity-score inverse probability of treatment-weighted Cox regression, we found evidence that LVNC-D was associated with a greater risk of death or transplantation (hazard ratio, 2.3; 95% CI, 1.4-3.8; P=0.0012). CONCLUSIONS: Symptomatic children with LVNC usually present in early infancy with a predominant dilated phenotype. Long-term outcomes are worse than for matched children with dilated cardiomyopathy.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Shi WY, Moreno-Betancur M, Nugent AW, et al. Long-Term Outcomes of Childhood Left Ventricular Noncompaction Cardiomyopathy: Results From a National Population-Based Study. Circulation. 2018. PMID: 29514799. doi:10.1161/CIRCULATIONAHA.117.032262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。